Lynparza 100 MG tablet UU 120S
Ended Awarded Last action
- Contract number
- SPE2DR26FCV8X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,172
Award facts
- Contract value 100% obligated
- $22,172.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Lynparza 100 mg tablets in a quantity of 120 units, with a ceiling value of $22,172.12. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for completion by January 13, 2026, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor for medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. The company's extensive federal contract portfolio demonstrates its capability to supply a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains. The delivery order for Lynparza, an oncology medication, is typical of AmerisourceBergen's role in supplying specialized brand-name and generic medications to support defense health operations. The IDC vehicle under which this order was issued reflects the company's established position as a primary pharmaceutical supplier and enables flexible fulfillment of federal medical supply requirements across global military healthcare networks.
Quick answers
Who was awarded contract SPE2DR26FCV8X?
SPE2DR26FCV8X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26FCV8X worth?
The government has obligated $22,172 on SPE2DR26FCV8X.
Is contract SPE2DR26FCV8X an order under another contract?
Yes. SPE2DR26FCV8X is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCV8X competed?
The extent of competition for SPE2DR26FCV8X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award